Insulet Corp (PODD)
260.12
-1.04
(-0.40%)
USD |
NASDAQ |
Nov 15, 16:00
259.96
-0.16
(-0.06%)
After-Hours: 20:00
Insulet Research and Development Expense (TTM): 201.00M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 201.00M |
| June 30, 2024 | 203.90M |
| March 31, 2024 | 205.10M |
| December 31, 2023 | 205.00M |
| September 30, 2023 | 212.50M |
| June 30, 2023 | 199.70M |
| March 31, 2023 | 187.20M |
| December 31, 2022 | 180.20M |
| September 30, 2022 | 172.50M |
| June 30, 2022 | 165.00M |
| March 31, 2022 | 162.50M |
| December 31, 2021 | 160.10M |
| September 30, 2021 | 156.60M |
| June 30, 2021 | 157.90M |
| March 31, 2021 | 152.00M |
| December 31, 2020 | 146.80M |
| September 30, 2020 | 144.00M |
| June 30, 2020 | 136.50M |
| March 31, 2020 | 135.30M |
| December 31, 2019 | 132.30M |
| September 30, 2019 | 130.20M |
| June 30, 2019 | 121.23M |
| March 31, 2019 | 107.03M |
| December 31, 2018 | 94.80M |
| September 30, 2018 | 81.43M |
| Date | Value |
|---|---|
| June 30, 2018 | 79.24M |
| March 31, 2018 | 78.47M |
| December 31, 2017 | 75.70M |
| September 30, 2017 | 71.70M |
| June 30, 2017 | 65.30M |
| March 31, 2017 | 60.22M |
| December 31, 2016 | 55.71M |
| September 30, 2016 | 52.57M |
| June 30, 2016 | 48.87M |
| March 31, 2016 | 47.99M |
| December 31, 2015 | 43.21M |
| September 30, 2015 | 37.60M |
| June 30, 2015 | 34.72M |
| March 31, 2015 | 29.33M |
| December 31, 2014 | 27.90M |
| September 30, 2014 | 27.04M |
| June 30, 2014 | 25.65M |
| March 31, 2014 | 24.15M |
| December 31, 2013 | 21.76M |
| September 30, 2013 | 21.19M |
| June 30, 2013 | 21.98M |
| March 31, 2013 | 23.32M |
| December 31, 2012 | 24.36M |
| September 30, 2012 | 24.32M |
| June 30, 2012 | 22.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
132.30M
Minimum
Dec 2019
212.50M
Maximum
Sep 2023
170.80M
Average
163.75M
Median
Research and Development Expense (TTM) Benchmarks
| Baxter International Inc | 754.00M |
| Boston Scientific Corp | 1.519B |
| Abbott Laboratories | 2.795B |
| Globus Medical Inc | 182.60M |
| Bioventus Inc | 13.66M |